Berberine (BR) has been proved to promote endothelial function. However, the exact mechanisms underlying the effect of BR on endothelial function are not completely clear. It has been demonstrated that endothelial progenitor cells (EPCs) contribute to improvement of endothelial function and C2 small artery elasticity index is a surrogate parameter for the clinical evaluation of endothelial function. We hypothesized that BR-induced mobilization of circulating EPCs is associated with BR-related improvement of endothelial function. To address this assumption, 15 healthy volunteers were recruited and received BR 0.4 g three times per day for 30 days. The number of circulating CD34/KDR double-positive cells as well as C1 large and C2 small artery elasticity indices were evaluated before and after BR therapy. The number of CD34/KDR doublepositive EPCs increased significantly after BR treatment (0.030 ± 0.020% vs 0.017 ± 0.010%, Po0.01). After 30-day BR therapy C2 increased significantly (6.21±2.80 ml per mm Hg Â 100 vs 4.06±2.67 ml per mm Hg Â 100, Po0.01) and C1 remained unchanged (10.79 ± 3.27 ml per mm Hg Â 10 vs 10.06 ± 2.08 ml per mm Hg Â 10, P40.05). The increment of CD34/KDR double-positive EPCs was positively correlated with the increment of C2 (r ¼ 0.68, Po0.01). We concluded that BR-induced mobilization of circulating EPCs contributes to improvement of small artery elasticity in healthy persons.
Introduction
It has been proved that endothelium plays a pivotal role in maintaining vascular homeostasis. 1 Restoration of endothelial function may be an important therapeutic target for cardiovascular diseases. It has been demonstrated that endothelial function is associated with arterial elasticity and C2 small artery elasticity index is a surrogate marker for the clinical evaluation of endothelial function. [2] [3] [4] Data have shown that circulating endothelial progenitor cells (EPCs) contribute to the maintenance of normal endothelial function and impaired EPCs number and function accelerate the impairment of arterial elasticity and endothelial function. [5] [6] [7] [8] Presently, upregulation of circulating EPCs is a novel therapeutic strategy for preventing and treating cardiovascular diseases.
Berberine (BR) is a plant alkaloid mainly found in rhizomes, roots and stem bulk of the plants such as the Berberidaceae, Ranunculaceae families and Chinese herb Huanglian. The compound is known to exhibit multiple pharmacological activities, including improving endothelial function, at least partially, through increasing endothelium-derived nitric oxide (NO) formation. 9, 10 Data have shown that NO also plays a pivotal role in the regulation of small artery elasticity and EPCs mobilization. 2, 4, 11 Until now, whether BR can mobilize EPCs and improve arterial elasticity, however, has not yet been elucidated. In the present study, we hypothesized that BR-mobilized EPCs contribute to BR-related improvement of arterial elasticity. To test this assumption, we measured the circulating EPCs and C1 large and C2 small artery elasticity indices by using flow cytometry and noninvasive pulse wave analysis in healthy volunteers before and after BR treatment, respectively.
Methods

Subjects
A total of 15 healthy volunteers were recruited (n ¼ 15, male/female ¼ 5/10). All subjects underwent a full medical history and examination including laboratory tests, and subjects with hypertension, diabetes mellitus, smoking, hypercholesterolaemia and other cardiovascular abnormalities were excluded. None of the subjects were taking any drugs for at least 2 weeks before starting this study. All the women were postmenopausal and had never used hormone supplementation before this study. All subjects gave written informed consent for the study, which was approved by the Ethics Committee of our hospital. All subjects received BR (Guangdong Huanan Pharmaceutical Co. Ltd, Dongguan, China) 0.4 g three times per day for 30 days. All indices were evaluated before and after 30 days of treatment.
Biochemical assays
After a fasting period of 12 h, peripheral venous blood samples were collected for determination. Serum total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) concentrations were measured on a Hitachi 7170A analyser using enzymatic methods by a specialist. Highsensitivity C-reactive protein (hsCRP) was measured at 550 nm with the use of the particle enhanced immunoturbidimetric assay (Orion Diagnostica, Espoo, Finland). Plasma glucose (Glu) was measured by the glucose hexokinase method (Roche Diagnostics, Basel, Switzerland). All the processes were performed by a single operator who was unaware of the subjects' state.
Radial arterial pulse waveform measurement Radial arterial pulse waves were recorded with an acoustic transducer using the CVProfilor DO-2020 CardioVascular System (Hypertension Diagnostics, Eagan, MN, USA) as previously reported. 2, 7 The process was performed in a controlled environment maintained at 23 1C after the participants had rested for at least 15 min in a supine position. The right wrist was splinted and a pressure sensor was placed over the maximal radial impulse and positioned to obtain a stable waveform with maximal sensitivity. A blood pressure cuff was placed over the left upper arm and inflated concurrently with the pulse waveform recording for calibration. Three measurements were taken and averaged. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were recorded. C1 large artery elasticity or capacitive compliance and C2 small artery elasticity or oscillatory compliance were calculated by the device. Elasticity indices are represented in units of millilitres per mm Hg ( Â 10 for C1 and Â 100 for C2).
Flow cytometry analysis
Flow cytometry analysis was performed as described previously with some modifications. 12 A volume of 100 ml of peripheral blood was incubated for 15 min in the dark with phycoerythrin-conjugated monoclonal antibody against human CD34 (Becton Dickinson, Franklin Lakes, NJ, USA) and rabbit polyclonal antibody against human vascular endothelial growth factor receptor-2 (VEGFR-2), namely kinase insert receptor (KDR) (Neomarkers, Fremont, CA, USA). The latter was detected with FITCconjugated goat against rabbit IgG (SouthernBiotech, Birmingham, UK). After incubation, cells were lysed, washed with phosphate-buffered saline (PBS) and fixed in 4% paraformaldehyde before analysis of 60 000 events after exclusion of debris and platelets. The number of circulating EPCs was evaluated by the ratio of CD34/KDR double-positive cells per 100 peripheral blood mononuclear cells (PBMNCs). Isotype-identical antibodies served as controls. Double colour flow cytometry analysis were performed by using a Coulter Elite flow cytometer and performed in duplicate. To assess the reproducibility of EPCs measurements, circulating EPCs were measured from the same subjects (n ¼ 15) from two separate blood samples, revealing a very close correlation (r ¼ 0.83, Po0.01).
Data and statistical analysis
Results are presented as mean±s.d. and analysed with SPSS software (version 13.0). Statistical significance was evaluated by paired t-test. Bivariate correlations were calculated according to Pearson's bivariate correlation analysis. Multiple regression analysis was conducted using the 'stepwise model'. A value of Po0.05 was considered significant. When we assumed that the C1 would achieve a 2.00 ml per mm Hg Â 10 increment compared with those of before BR treatment and with an s.d. of the mean differences of 3.00 ml per mm Hg Â 10, giving our study 80% statistical power and an a error of less than 5%, we would need a sample size of at least 15 volunteers.
Results
Volunteers' baseline characteristics were shown in Table 1 . BR treatment significantly decreased TC, LDL-C and Glu (Po0.01). hsCRP, TG, SBP and DBP remained unchanged before and after BR treatment (P40.05). As shown in Figure 1 , C2 increased significantly (6.21±2.80 ml per mm Hg Â 100 vs 4.06 ± 2.67 ml per mm Hg Â 100, Po0.01) and C1 did not show statistical difference (10.79 ± 3.27 ml per mm Hg Â 10 vs 10.06±2.08 ml per mm Hg Â 10, P40.05), compared with their initiative state. In the present study, CD34/KDR double-positive cells represented the circulating EPCs. After 30 days of BR therapy the ratio of CD34/KDR double-positive cells increased significantly compared with their initiative state (0.030±0.020% vs 0.017±0.010%, Po0.01; Figure 2) .
DEPCs, DC2, DTC, DLDL-C, DGlu, DSBP and DDBP were expressed as the percent change relative to that at the initiative state. Pearson's bivariate correlation analysis showed that DC2 positively correlated with DEPCs (r ¼ 0.68, Po0.01, Figure 3 ). DC2 and DEPCs did not correlate with DTC, DLDL-C, DGlu, DSBP and DDBP, respectively (P40.05). A further stepwise multiple regression model was constructed to investigated the factors related to DC2, including DEPC, DTC, DLDL-C, DGlu, DSBP and DDBP, which showed that only DEPC (r ¼ 0.68, Po0.01) was identified as the independent value for determining DC2 (R 2 ¼ 0.46, Po0.01, Table 2 .) and there was no independent value for determining DEPC, including DTC, DLDL-C, DGlu, DSBP and DDBP.
Discussion
The present study demonstrated that BR therapy increased the number of circulating EPCs by using flow cytometry in healthy persons, and in parallel C2 small artery elasticity index was also enhanced. The increment of CD34/KDR double-positive EPCs was associated with improved small artery elasticity index, a sensitive surrogate marker of endothelial function evaluation. The present study firstly proved that BR-induced upregulation of circulating EPCs contributes to improvement of small artery elasticity in healthy persons.
Normal endothelial function plays a pivotal role in maintaining cardiovascular homeostasis. 1 Means of evaluating endothelial function are important for providing insights into arteries at risk for the vascular homeostasis. Artery elasticity identified by pulse wave analysis is a newly developed method for the evaluation of vascular function.
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However, there were some arguments about the role of small artery elasticity C2 assessed by radial arterial pulse waveform analysis in evaluating endothelial function. The discrepancy of experimental methods in different laboratories may be related to the arguments. Based on the results in our laboratory and other publications, [2] [3] [4] we think that small artery elasticity is closely related to endothelial function. Impaired small artery elasticity is associated with cardiovascular risk factors and inhibition of NO formation decreases small artery elasticity index, indicating that the state of small artery elasticity reflects the balance between endothelial injury and repair. Furthermore, we have established that diminished circulating EPCs with subsequently impaired endothelial repair and function contributed to reduced artery elasticity in humans with aging. 7 BR, a well known Chinese herb, exerts protective effects on vascular endothelium, at least partially, through increasing NO formation. 9, 10 However, the further mechanisms by which BR exerts protective effects on endothelial function should be further investigated. In the present study, we hypothesized that the beneficial effects of BR on endothelial function may be related to BR-induced upregulation of circulating EPCs. Data have shown that EPCs reflects an endogenous repair capacity to prevent and restore endothelial injury and dysfunction. 5, 6, 13, 14 To test the effects of BR on EPCs and endothelial function, in healthy volunteers the ratio of CD34/KDR double-positive cells was detected by flow cytometry before and after BR treatment. The large and small artery elasticity indices identified by noninvasive pulse wave analysis were also measured. We found that BR treatment leads to increased circulating CD34/KDR double-positive EPCs and in parallel, small artery elasticity index was also improved after BR treatment. There was a positive correlation between the increment of CD34/ KDR double-positive cells and small artery elasticity index. Therefore, based on our present study and previous results, we suggested that BR-induced mobilization of EPCs may be at least in part involved in the process of BR-mediated vascular protection.
C1 large artery elasticity index is determined by the interaction of the arterial wall relaxant and stiff state, which is influenced by the linking between collagen, elastin and smooth muscle cells within the arterial wall. 15, 16 The improvement in endothelial function induced by BR treatment may more likely facilitate the alteration of large artery structure towards the relaxant state that increases large artery compliance or C1 elasticity index. In the present study, C1 did not change significantly after 30-day BR therapy. We reasoned that the beneficial effect of BR on large artery structure cannot be achieved within 30 days. Therefore, further studies should be performed to investigate the effect of BR on large artery elasticity index.
Data reported here show that BR is a potent agent to improve the small artery elasticity, indicating that BR may have beneficial effects on vascular homeostasis. In addition, our present study and previous investigations have proved that BR has other multiple salutary effects on cardiovascular system, including antihyperglycemic, anti-hypertensive, cholesterol-lowering and cardiac-protective activities. [17] [18] [19] [20] It seems logical that BR may exert multiple protections on vascular function.
There are several limitations in the present study. Firstly, the sample size of the study was small and the volunteers did not include patients with hypertension. Therefore, large-scale, randomized, controlled study is needed to confirm the clinical implication of BR-induced EPC mobilization. Secondly, we proposed that BR-induced EPC mobilization contributes to improved arterial elasticity, but the definitive cause-and-effect relation between them, however requires further studies. As BR has been shown to induce NO release, the effect of BR on small artery elasticity may be due to BR-induced NO release. The lack of measurement of NO level in this study should be considered as a limitation. Lastly, the molecular mechanisms responsible for BR-induced mobilization of EPCs and the effects of BR on EPCs functions remain to be elucidated.
In summary, the present study firstly demonstrated that BR-induced mobilization of circulating EPCs contributed to upregulation of small artery elasticity. Our results provided a novel mechanism responsible for BR-mediated vascular protection. Further study should be performed to investigate the clinical effects of BR on EPCs-related vascular events. K Berberine (BR) improves endothelial function, at least partially, through increasing endothelium-derived nitric oxide (NO) formation.
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K Effect of BR on circulating EPCs and its relation to C2, however, has not been investigated.
What this study adds K BR therapy in healthy volunteers leads to an increase in the number and function of circulating EPCs detecting by flow cytometry. K BR improves small arterial elasticity, a sensitive marker of endothelial function evaluation. There is close association between circulating EPCs and C2. K The present study provides a novel insight into the molecular mechanisms of BR-mediated vascular protection.
